The five competencies of continuous regulatory compliance
April 28, 2017Medical Communications pharmafile, regulatory compliance
Look at any country or region with a strong generic pharmaceutical and active ingredient manufacturing sector, and you are sure …
SAB Biotherapeutics moves to bolster board
April 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
SAB Biotherapeutics, a clinical-stage biopharmaceutical development company, announced that it had appointed Thorkil Kastberg Christensen to its Board of Directors. …
Blood test able to detect cancer a year in advance
April 27, 2017Research and Development Cancer Research UK, Francis Crick Institute, cancer research
A team at the Francis Crick Institute, based in London, has discovered a new way of analysing blood in patients …
Mental health spending to sink by £4.5 million
April 27, 2017Medical Communications NHS, mental health
Here at Pharmafocus, we highlighted the state of mental health research and the alternative paths that are being trod to …
Mental health: Time for a new kind of therapy?
April 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mental health
It’s no secret that mental health is not taken as seriously as its physical counterpart. It has been an uphill …
Cheap drug could prevent thousands of maternal deaths worldwide
April 27, 2017Research and Development postpartum haemorrhage
A drug that has been available to patients for many years may have found a new use to prevent mothers …
Teva has another high profile role to fill
April 27, 2017Sales and Marketing Eyal Desheh, Teva, Teva Pharmaceuticals
Teva’s gaps at the top level of its structure continue to build, as Eyal Desheh is set to leave his …
ABPI calls for a “world-class NHS” with 2017 General Election Manifesto
April 27, 2017Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Theresa May, general election
With Theresa May’s announcement of a snap election in earlier this month, the life sciences industry erupted into fiery discourse. …
AZ’s Tagrisso continues successes with EU approval
April 26, 2017Research and Development, Sales and Marketing AstraZeneca, EU, European Commission, NSCLC, Tagrisso
More good news for AstraZeneca’s Tagrisso (osimertinib), as the company announces that the European Commission has granted the drug full …
FDA condemns 14 companies selling fraudulent cancer ‘cures’ online
April 26, 2017Research and Development, Sales and Marketing Cancer, FDA
The FDA has struck out against a wave of companies offering cancer treatments online which fraudulently claim to be able …
Research identifies marker for aggressive ovarian cancer
April 26, 2017Research and Development Cancer, ovarian cancer
Scientists have identified a marker which they believe can inform whether a tumour will become more aggressive and pose a …
Sanofi launches lawsuit against Mylan over “illegal business practices”
April 26, 2017Research and Development, Sales and Marketing Auvi-Q, Mylan, Sanofi, epipen, lawsuit
In a move that is sure to pile even more pressure onto Mylan after the company’s recent woes, Sanofi has …
The May 2017 issue of Pharmafocus is now live!
April 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus
The latest edition of Pharmafocus is available to read now! In this issue we delve into pharma’s reaction to the …
Rasna Therapeutics appoints new CEO
April 25, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Rasna Therapeutics, the UK-based biotech that specialises in developing treatments for leukaemia, has announced the appointment of a new CEO. …
Pharma industry calls for EMA relocation by June in open EFPIA letter
April 25, 2017Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA
Heads of research from 19 of the biggest players in the industry have called for a decision to be made …
Indian government goes to war over 75% stent price reduction
April 25, 2017Manufacturing and Production India, cardiac stents
The National Pharmaceutical Pricing Authority (NPPA), India’s drug pricing regulator, moved to lower the price of the newest generation of …
EMA gives positive opinion on Biogen’s spinal muscular atrophy drug Spinraza
April 25, 2017Manufacturing and Production, Sales and Marketing Biogen, Ionis, Spinraza, spinal muscular atrophy
Biogen has revealed that Spinraza (nusinersen), its treatment for spinal muscular atrophy (SMA) , has received a positive opinion from …
Quarter of cancer patients visit GP three times with no diagnosis
April 25, 2017Manufacturing and Production, Research and Development Cancer, GP, NHS, oncology
A recent study, published in the British Journal of General Practice, has found that 23% of those suffering from cancer …
Japanese pharma expects 17% growth throughout 2017
April 25, 2017Manufacturing and Production CPhI, Japan
Pharma companies attending CPhI Japan are expecting a 17% growth of the country’s market throughout the year, according to data …
Five crucial facts about mental health
April 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, anxiety, depression, mental health, world health day
7 April marked this year’s World Health Day, and for 2017 the WHO selected depression as the annual focus. Prevalent …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
